GHR Foundation
GHR Foundation is an independent non-profit organization based in Minneapolis, Minnesota, established in 1965. The foundation is dedicated to fostering transformational changes in education, health, and global development. It focuses on promoting equity, dignity, and care across the globe while partnering with various organizations to address critical issues. Key initiatives include efforts to prevent Alzheimer's disease and related dementias, support the growth of an inclusive global Catholic Church that serves marginalized communities, and enhance access to financial empowerment and educational opportunities in its local area of Minneapolis and St. Paul. The foundation's management team oversees its assets to ensure effective implementation of its mission.
C2N Diagnostics
Grant in 2024
C2N Diagnostics, LLC is a privately held company focused on protein diagnostics and therapeutic discovery for progressive neurodegenerative diseases, particularly Alzheimer's disease. Founded in late 2007 by Drs. David Holtzman and Randall Bateman from Washington University School of Medicine, alongside LifeTech Research, the company is based at the Center for Emerging Technologies in St. Louis. C2N Diagnostics utilizes advanced mass spectrometry techniques to offer precise identification, quantification, and monitoring of proteins and biomolecules associated with neurological disorders. This innovative approach enables healthcare professionals to detect and characterize neurocognitive disorders more accurately, enhancing the potential for effective diagnosis and treatment strategies.
Horizon Next
Grant in 2023
Nowadays AI, Robots and automation are trend, but very soon autonomous devices, car and other machines will be everywhere at our daily life. From our over the horizon vision, "Horizon Next" team is bringing innovation to life, aiming equal and wealth life for humans.
C2N Diagnostics
Venture Round in 2023
C2N Diagnostics, LLC is a privately held company focused on protein diagnostics and therapeutic discovery for progressive neurodegenerative diseases, particularly Alzheimer's disease. Founded in late 2007 by Drs. David Holtzman and Randall Bateman from Washington University School of Medicine, alongside LifeTech Research, the company is based at the Center for Emerging Technologies in St. Louis. C2N Diagnostics utilizes advanced mass spectrometry techniques to offer precise identification, quantification, and monitoring of proteins and biomolecules associated with neurological disorders. This innovative approach enables healthcare professionals to detect and characterize neurocognitive disorders more accurately, enhancing the potential for effective diagnosis and treatment strategies.
Braille Teach
Grant in 2022
Braille Teach is a device with audio feedback to help blind and visually impaired people learn the Braille alphabet.
Horizon Next
Grant in 2022
Nowadays AI, Robots and automation are trend, but very soon autonomous devices, car and other machines will be everywhere at our daily life. From our over the horizon vision, "Horizon Next" team is bringing innovation to life, aiming equal and wealth life for humans.
C2N Diagnostics
Grant in 2020
C2N Diagnostics, LLC is a privately held company focused on protein diagnostics and therapeutic discovery for progressive neurodegenerative diseases, particularly Alzheimer's disease. Founded in late 2007 by Drs. David Holtzman and Randall Bateman from Washington University School of Medicine, alongside LifeTech Research, the company is based at the Center for Emerging Technologies in St. Louis. C2N Diagnostics utilizes advanced mass spectrometry techniques to offer precise identification, quantification, and monitoring of proteins and biomolecules associated with neurological disorders. This innovative approach enables healthcare professionals to detect and characterize neurocognitive disorders more accurately, enhancing the potential for effective diagnosis and treatment strategies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.